Supreme Court lets Medicare drug price negotiations stand
Digest more
The Biden administration is expected to announce, by Sept. 1, the first 10 prescription drugs it will target in its newly authorized drug price “negotiation” regime. Under the Inflation Reduction Act (more properly dubbed the Innovation Reduction Act ...
WASHINGTON (AP) — Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world’s best-selling multiple sclerosis drug to competition from generic rivals next month. The decision is a victory ...
The pharmaceutical industry’s top lobbying group filed a lawsuit Wednesday arguing that a law enacted last year allowing Medicare to directly negotiate some prescription drug prices is unconstitutional. The Pharmaceutical Research and Manufacturers of ...
Drugmaker Novo Nordisk is taking action to curb the massively popular compounded semaglutide industry, which provides copies of its blockbuster weight-loss drugs Ozempic and Wegovy to patients—often for much lower prices. The Danish pharmaceutical ...